Alnylam Pharmaceuticals
ALNY
#880
Rank
$21.44 B
Marketcap
🇺🇸 USA
Country
$182.41
Share price
0.33%
Change (1 day)
-0.33%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Market capitalization of Alnylam Pharmaceuticals (ALNY)
Market cap: $21.44 Billion
As of July 2021 Alnylam Pharmaceuticals has a market cap of $21.44 Billion. This makes Alnylam Pharmaceuticals the world's 880th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Alnylam Pharmaceuticals from 2004 to 2021
| Year | Market cap | Change |
|---|---|---|
| 2021 | $21.50 B | 42.44% |
| 2020 | $15.10 B | 16.87% |
| 2019 | $12.92 B | 75.15% |
| 2018 | $7.37 B | -41.45% |
| 2017 | $12.59 B | 292.16% |
| 2016 | $3.21 B | -59.89% |
| 2015 | $8.01 B | 6.97% |
| 2014 | $7.48 B | 82.71% |
| 2013 | $4.09 B | 327.85% |
| 2012 | $0.95 B | 175.09% |
| 2011 | $0.34 B | -16.59% |
| 2010 | $0.41 B | -43.36% |
| 2009 | $0.73 B | -28.02% |
| 2008 | $1.02 B | -13.62% |
| 2007 | $1.18 B | 49.54% |
| 2006 | $0.79 B | 207.77% |
| 2005 | $0.25 B | 78.85% |
| 2004 | $0.14 B |